Hepatitis Panel, Acute with Reflex to HBsAg Confirmation and Reflex to HCV by Quantitative NAAT
Also known as: HEPACUTEQR
Use
This test is the preferred panel for evaluating symptomatic patients for viral hepatitis. It includes tests for HAV IgM, HBV core antibody IgM, HBV surface antigen, and HCV antibody, with reflex to HCV by quantitative NAAT when needed. It helps in diagnosing Hepatitis A, B, and C infections in patients with acute symptoms, aiding in determining the etiological agent responsible for the infection.
Special Instructions
Not provided.
Limitations
This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/P). The test is primarily intended for evaluating symptomatic cases of hepatitis and may not provide definitive results for chronic or inactive infections. False positives may occur in certain cases, and clinical correlation is required to interpret test results correctly.
New York Approved
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 48767-8 - Annotation comment Imp
- 5196-1 - HBV surface Ag SerPl Ql IA
- 24113-3 - HBV core IgM SerPl Ql IA
- 13950-1 - HAV IgM SerPl Ql IA
- 57006-9 - HCV IgG Ser IA-aCnc
- 13955-0 - HCV Ab SerPl Ql IA
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
3.0 mL
Minimum Volume
2.5 mL
Container
ARUP standard transport tube
Collection Instructions
Separate serum from cells ASAP or within 2 hours of collection. Transfer the serum to a dedicated ARUP transport tube for testing.
Causes for Rejection
Heparinized plasma, specimens containing particulate material, heat-inactivated, severely hemolyzed, or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 12 hours |
| Refrigerated | 6 days |
| Frozen | 2 months (avoid freeze/thaw cycles) |
Other tests from different labs that may be relevant